[肝胆速递] 了解乙肝和丙肝的宿主遗传因素

bigben446

了解乙肝和丙肝的宿主遗传因素
Understanding the Host Genetics of Chronic Hepatitis B and C

[肝胆速递]： 综述了影响乙肝和丙肝感染中的宿主遗传因素，特别是IL-28和IL-29，其中IL-28B的遗传分析可用于临床上对干扰素及利巴韦林治疗结果的预测。

https://www.thieme-connect.com/ejournals/abstract/sld/doi/10.1055/s-0031-1276642

Mark Thursz1, Leland Yee2, Salim Khakoo1

1 Hepatology and Gastroenterology Section, Department of Medicine, Imperial College, London, United Kingdom 2 Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania ABSTRACT The outcome of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are heterogeneous, ranging from an asymptomatic self-limiting infection to cirrhosis and hepatocellular carcinoma. Several viral environmental and demographic variables have been identified as determinants of disease outcome, but these fail to explain a large proportion of the variability. Evidence from twin studies suggests that the host genetic background is an important contributor to disease outcome. Identification of genes that influence the outcome of infection has been attempted using a wide spectrum of approaches including candidate gene disease association studies, genome-wide scanning in affected sibling pairs and most recently genome-wide association studies. We summarize the main findings from a large number of studies in this review. Many studies have focused on the MHC loci from which several reproducible disease associations have been identified. More recently, genome-wide association studies have identified an important locus within the IL-28 - Il-29 region on chromosome 29, which appears to be a major determinant of the treatment response in patients infected with HCV and also a determinant of spontaneous resolution of infection. Translation of the genetic architecture of chronic viral hepatitis into therapeutic opportunities has been slow to proceed. One clinical trial and one drug development program have been based on genetic discoveries. The use of IL-28B genotyping to predict the response to pegylated interferon and ribavirin may also find its way into clinical practice. Indeed, stratification of clinical trial populations based on IL-28B genotype is already considered mandatory.

(6.合.彩).足球.篮球...各类投注开户下注

第一投注.现金网:招代理年薪10万以上:6668.cc